Concepedia

Kah Hiing John Ling

KH

Statistics

Publications

13

Citations

431

H-Index

12

Active since

1990

Affiliations

Gilead Sciences (United States)(Current)

Kah Hiing John Ling is an author at Gilead Sciences (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1990–2021

13

Publications

13

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment

Joseph M. Custodio, Marshall W. Fordyce, William Garner et al. · Antimicrobial Agents and Chemotherapy · 2016 · 74 citations · Full text

, , +17

Active site dynamics of xylene hydroxylation by cytochrome P-450 as revealed by kinetic deuterium isotope effects

Robert P. Hanzlik, Kah Hiing John Ling · Journal of the American Chemical Society · 1993 · 57 citations

, , +14

Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies

Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski et al. · Analytical Biochemistry · 2021 · 56 citations · Full text

, , +17

Active site dynamics of toluene hydroxylation by cytochrome P-450

Robert P. Hanzlik, Kah Hiing John Ling · The Journal of Organic Chemistry · 1990 · 44 citations

, , +13

Pharmacokinetics of cobicistat boosted‐elvitegravir administered in combination with rosuvastatin

Joseph M. Custodio, Hui Wang, Hao Jia et al. · The Journal of Clinical Pharmacology · 2013 · 39 citations

, , +15

1–5 of 13